Eric Venker
Presidente presso ROIVANT SCIENCES LTD.
Patrimonio netto: 5 M $ in data 30/04/2024
Posizioni attive di Eric Venker
Società | Posizione | Inizio | Fine |
---|---|---|---|
IMMUNOVANT, INC. | Direttore/Membro del Consiglio | 18/02/2020 | - |
ROIVANT SCIENCES LTD. | Direttore operativo | 01/11/2018 | - |
Presidente | 01/01/2021 | - | |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Direttore operativo | 01/11/2018 | - |
Presidente | 01/01/2021 | - | |
Corporate Officer/Principal | 01/01/2017 | 01/11/2018 | |
Aruvant Sciences, Inc.
Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Direttore/Membro del Consiglio | - | - |
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Direttore/Membro del Consiglio | - | - |
Direttore operativo | - | - | |
Roivant Social Ventures, Inc. | Direttore/Membro del Consiglio | 01/01/2014 | - |
Storia della carriera di Eric Venker
Precedenti posizioni note di Eric Venker
Società | Posizione | Inizio | Fine |
---|---|---|---|
SIO GENE THERAPIES INC. | Direttore/Membro del Consiglio | 17/02/2020 | 05/04/2023 |
ARBUTUS BIOPHARMA CORPORATION | Direttore/Membro del Consiglio | 01/02/2020 | 25/05/2022 |
Independent Dir/Board Member | 01/02/2020 | 25/05/2022 | |
ROIVANT SCIENCES LTD. | Direttore operativo | - | - |
Presidente | - | - | |
░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formazione di Eric Venker
Yale School of Medicine | Doctorate Degree |
St. Louis College of Pharmacy | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 11 |
Svizzera | 2 |
Regno Unito | 2 |
Posizioni
Director/Board Member | 6 |
Chief Operating Officer | 4 |
President | 3 |
Settori
Health Technology | 8 |
Consumer Services | 4 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
IMMUNOVANT, INC. | Health Technology |
ARBUTUS BIOPHARMA CORPORATION | Health Technology |
ROIVANT SCIENCES LTD. | Health Technology |
Aziende private | 6 |
---|---|
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
Sio Gene Therapies, Inc.
Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Aruvant Sciences, Inc.
Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Health Technology |
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Health Technology |
Montes Archimedes Acquisition Corp.
Montes Archimedes Acquisition Corp. Financial ConglomeratesFinance Montes Archimedes Acquisition Corp operates as a blank check company. It is formed for the business purpose to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded James C. Momtazee and Maria C. Walker on July 6, 2020 and is headquartered in Menlo Park, CA. | Finance |
Roivant Social Ventures, Inc. |
- Borsa valori
- Insiders
- Eric Venker
- Esperienza